Potential of FX06 to prevent disease progression in hospitalized non-intubated COVID-19 patients — the randomized, EU-wide, placebo-controlled, phase II study design of IXION
DiscussionWith IXION, the multidisciplinary consortium aims to deliver a new therapy in addition to standard care against SARS-CoV-2 for the clinical management of COVID-19 during mild and moderate stages. Potential limitations might refer to a lack of recruiting and drop-out due to various possible protocol violations. While we controlled for drop-outs in the same size estimation, recruitment problems may be subject to external problems difficult to control for.Trial registrationEudraCT2021-005059-35. Registered on 12 December 2021. Study Code TMP-2204-2021-47. (Source: Trials)
Source: Trials - August 19, 2022 Category: Research Source Type: clinical trials

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer
Condition:   Small-cell Lung Cancer Interventions:   Procedure: Thoracic radiotherapy;   Drug: Chemo-immunotherapy Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital;   Haukeland University Hospital;   University Hospital of North Norway;   Alesund Hospital;   Helse Stavanger HF;   Oslo University Hospital;   Helse Nord-Trøndelag HF;   Helse Fonna;   Drammen  sykehus;   University Hospital, Akershus;   Odense University Hospital;   Rigshospitalet, Denmark;   Erasmus Medical Center;   Sahlgrenska University Hospital, Sweden;   KarolinskaÂ...
Source: ClinicalTrials.gov - February 4, 2022 Category: Research Source Type: clinical trials

Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging
Condition:   Coronary Artery Disease;Heart Failure;Hypertrophic Cardiomyopathy; Congenital and Valvular Heart Disease; Post-chest Radio/Chemiotherapy; Heart Transplantation Interventions:   Diagnostic Test: ABCDE-Stress Echo;   Diagnostic Test: SE diastolic assessment;   Diagnostic Test: SE Right ventricular function assessment;   Diagnostic Test: SE in heart donors Sponsors:   Fatebenefratelli Hospital;   Institute oif Clinical Physiology,CNR, Pisa Italy;   Mayo Clinic;   Hospital Sao Vicente de Paulo e Hospital de Cidade, Passo Fundo, Brasil;   Cardarelli Hospital, Naples, Italy;   Ospeda...
Source: ClinicalTrials.gov - October 18, 2021 Category: Research Source Type: clinical trials